Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine in Social Anxiety Disorder
NCT00215254Phase 3Completed
- Sponsor
- Duke University
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in Social Anxiety Disorder (SAD), sponsored by Duke University. Started Mar 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00215254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215254.